Home VacV Biotech

VacV Biotech

VacV Biotech

VacV Biotech
Category
Business Description
VacV is a cancer immunotherapy company developing viral-based therapies for cancer. Its promising pipeline of easy-to-administer treatments includes features that offer significant advantages compared to existing treatment options. The company modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV).
Based in
London
Tags
Medical & Health, immunotherapy, software
Total Funding
Between €2.5 million-5 million
Founded
2022
Website
https://vacvbtx.com/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as VacV Biotech? We're happy to assist you with our Startup Sourcing service.